Differences Anti-Clot Burden and Benefits Treatment Scale (ACTS) and SWAN score (on satisfaction compared to warfarin) between those who were treated with apixaban and rivaroxaban (mean and range).
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接：
官方服务：
资源简介：
Higher scores reflect greater satisfaction/less burden.
创建时间：
2020-06-04
